Helen Collins
Chief Tech/Sci/R&D Officer bei ENLIVEN THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Aktive Positionen von Helen Collins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KURA ONCOLOGY, INC. | Director/Board Member | 29.07.2021 | - |
Independent Dir/Board Member | 29.07.2021 | - | |
ENLIVEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 23.02.2023 | - |
IO BIOTECH, INC. | Director/Board Member | 09.11.2023 | - |
Independent Dir/Board Member | 09.11.2023 | - |
Karriereverlauf von Helen Collins
Ehemalige bekannte Positionen von Helen Collins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FIVE PRIME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 20.03.2017 | 16.04.2021 |
Redwood Regional Medical Group, Inc.
Redwood Regional Medical Group, Inc. Medical/Nursing ServicesHealth Services Part of Providence St. Joseph Health, Redwood Regional Medical Group, Inc. is a private company that provides medical radiology, oncology, orthopedics, and surgery services. The company is based in Santa Rosa, CA. Redwood Regional Medical Group was acquired by Annadel Medical Group, Inc. on March 31, 2014. | President | 01.01.2006 | 01.01.2009 |
North Bay Cancer Alliance, Inc.
North Bay Cancer Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services North Bay Cancer Alliance, Inc. provides individual and family social services. The non-profit company is based in Santa Rosa. The American company was founded by Helen Collins. | Founder | 01.01.2005 | - |
Ausbildung von Helen Collins
Bryn Mawr College | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Dänemark | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
KURA ONCOLOGY, INC. | Health Technology |
IO BIOTECH, INC. | Health Technology |
ENLIVEN THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Redwood Regional Medical Group, Inc.
Redwood Regional Medical Group, Inc. Medical/Nursing ServicesHealth Services Part of Providence St. Joseph Health, Redwood Regional Medical Group, Inc. is a private company that provides medical radiology, oncology, orthopedics, and surgery services. The company is based in Santa Rosa, CA. Redwood Regional Medical Group was acquired by Annadel Medical Group, Inc. on March 31, 2014. | Health Services |
North Bay Cancer Alliance, Inc.
North Bay Cancer Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services North Bay Cancer Alliance, Inc. provides individual and family social services. The non-profit company is based in Santa Rosa. The American company was founded by Helen Collins. | Commercial Services |
- Börse
- Insiders
- Helen Collins
- Erfahrung